智通财经APP获悉，云顶新耀(01952)早盘涨超5%，截至发稿，涨4.75%，报35.7港元，成交额4424.98万港元。
消息面上，云顶新耀近期公告，原研产品布地奈德肠溶胶囊(耐赋康)专利维权取得关键进展：广州知识产权法院已于2026年2月26日作出民事裁定书，全面支持公司提出的诉前行为保全申请，并责令相关仿制药企业立即停止侵权行为并停止挂网，该裁定自作出之日起立即执行。据悉，2025年12月，海南合瑞制药的布地奈德肠溶胶囊首仿获批上市。
智通财经APP获悉，云顶新耀(01952)早盘涨超5%，截至发稿，涨4.75%，报35.7港元，成交额4424.98万港元。
消息面上，云顶新耀近期公告，原研产品布地奈德肠溶胶囊(耐赋康)专利维权取得关键进展：广州知识产权法院已于2026年2月26日作出民事裁定书，全面支持公司提出的诉前行为保全申请，并责令相关仿制药企业立即停止侵权行为并停止挂网，该裁定自作出之日起立即执行。据悉，2025年12月，海南合瑞制药的布地奈德肠溶胶囊首仿获批上市。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.